Infectious Diseases

502 questions

Question 401Question →

A 74-year-old woman is evaluated in the outpatient clinic for medical clearance 3 days prior to an elective right total hip arthroplasty. Her medical history includes well-controlled type 2 diabetes mellitus, essential hypertension, and osteoarthritis. She reports feeling well and explicitly denies fever, chills, flank pain, dysuria, or increased urinary frequency. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 128/78 mmHg, and a pulse of 76/min. Physical examination is unremarkable with no costovertebral angle tenderness or suprapubic pain. As part of a preoperative protocol mandated by the surgical center, a urinalysis and urine culture are obtained. The urinalysis reveals a specific gravity of 1.018, pH of 6.5, positive leukocyte esterase, positive nitrites, and 45 white blood cells per high-power field. Two days later, the urine culture grows >105>10^5 CFU/mL of *Klebsiella pneumoniae*. Antimicrobial susceptibility testing indicates the isolate is susceptible to cephalexin, ciprofloxacin, and trimethoprim-sulfamethoxazole. Which of the following is the most appropriate management regarding the patient's urinary findings?

Show answer & explanation

Answer: Proceed with the scheduled surgery without prescribing antimicrobial therapy for the urinary findings

Answer

Proceed with the scheduled surgery without prescribing antimicrobial therapy for the urinary findings
The correct approach is to proceed with the scheduled surgery without antimicrobial therapy. This patient has asymptomatic bacteriuria (ASB), which is defined as the presence of bacteria in the urine in the absence of signs or symptoms of a urinary tract infection (UTI). Crucially, the presence of pyuria (white blood cells) or a positive leukocyte esterase on urinalysis is highly prevalent in ASB and does not differentiate it from a true symptomatic UTI. Clinical guidelines strictly recommend against screening for or treating ASB, with two major exceptions: pregnant patients and patients undergoing urologic procedures where mucosal trauma is anticipated. For all other patients, including the elderly, patients with diabetes, and those undergoing non-urologic surgery such as total joint arthroplasty, treating ASB provides no benefit and does not reduce the risk of surgical site infections or prosthetic joint infections. Instead, treating ASB violates antibiotic stewardship principles by needlessly exposing patients to medication side effects, increasing the risk of Clostridioides difficile infection, and promoting antimicrobial resistance.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has significant bacteriuria and pyuria (>10^5 CFU/mL Klebsiella, 45 WBCs/hpf) but is completely devoid of systemic or localized urinary symptoms.
Correlating objective laboratory data with clinical symptoms is necessary to differentiate true infection from colonization.
2
Establish the correct diagnosis for the urinary findings.
The diagnosis is asymptomatic bacteriuria (ASB).
ASB is defined by a positive urine culture in a patient without urinary symptoms. The presence of pyuria (white blood cells) does not alter this diagnosis and should not be used to justify antibiotic therapy.
3
Apply infectious disease guidelines for the treatment of ASB.
Treatment of ASB is indicated ONLY in pregnant patients and those undergoing urologic procedures with anticipated mucosal trauma.
Treating ASB outside of these specific indications provides no clinical benefit and increases the risk of adverse drug events and antimicrobial resistance.
4
Determine the next best step for a patient undergoing orthopedic surgery.
No intervention for the bacteriuria is required; proceed with the surgery.
Orthopedic surgery (such as hip arthroplasty) is a non-urologic procedure. Treating ASB does not decrease the rate of prosthetic joint infection.

Key Concept

Asymptomatic bacteriuria requires no treatment prior to non-urologic procedures, including orthopedic arthroplasty, even in the presence of pyuria.
Question 402Question →

A 32-year-old man comes to the clinic for follow-up of a diarrheal illness. Three days ago, he developed fever, diffuse abdominal cramping, and multiple episodes of watery, non-bloody diarrhea after attending a family picnic. He was seen at an urgent care clinic yesterday where a stool culture was obtained and intravenous fluids were administered. Today, he reports that his fever has resolved and his diarrhea is beginning to improve, though he still has 2 to 3 loose stools per day. He is able to tolerate oral fluids and feels well-hydrated. His temperature is 37.1°C (98.8°F), blood pressure is 122/80 mmHg, and pulse is 76/min. The urgent care clinic forwards his stool culture results, which are positive for non-typhoidal *Salmonella enterica*. Susceptibility testing shows the isolate is pan-susceptible. Which of the following is the most appropriate antimicrobial management?

Show answer & explanation

Answer: No antimicrobial therapy is indicated

Answer

No antimicrobial therapy is indicated
The correct answer is that no antimicrobial therapy is indicated. This patient is a healthy young adult presenting with a resolving case of uncomplicated non-typhoidal Salmonella gastroenteritis. In immunocompetent individuals with mild to moderate disease, antimicrobial therapy is not indicated because it does not significantly shorten the duration of symptoms. Furthermore, antibiotic therapy can paradoxically increase the risk of prolonged asymptomatic carriage and fecal shedding of the organism. Therefore, standard management for uncomplicated cases relies strictly on supportive care with oral fluid and electrolyte replacement.

Step-by-Step Solution

1
Assess the patient's clinical status and risk factors.
The patient is a healthy 32-year-old with improving diarrhea, normal vital signs, and no immunocompromising conditions.
Determines whether the patient falls into a high-risk category that would require antibiotic therapy.
2
Interpret the laboratory findings in the context of the clinical picture.
Stool culture is positive for non-typhoidal Salmonella, but symptoms are resolving with supportive care.
Identifies the pathogen to guide specific management decisions.
3
Apply standard treatment guidelines for non-typhoidal Salmonella.
Antibiotics are withheld; management continues with supportive care alone.
In immunocompetent hosts, antibiotics for Salmonella gastroenteritis do not improve outcomes and may prolong bacterial shedding.

Key Concept

Uncomplicated non-typhoidal Salmonella gastroenteritis in immunocompetent patients should be managed with supportive care only, as antibiotics can prolong fecal shedding of the organism.
Question 403Question →

A 62-year-old man with a 15-year history of poorly controlled type 2 diabetes mellitus and peripheral neuropathy is evaluated in the clinic for a chronic right foot ulcer. He first noticed the ulcer 6 weeks ago. The patient is afebrile, and his vital signs are strictly within normal limits. On physical examination, there is a 3×33 \times 3 cm non-tender ulcer on the plantar surface of the right first metatarsal head. There is no surrounding erythema, warmth, fluctuance, or purulent drainage. A sterile metal probe is introduced into the ulcer and easily palpates a hard, gritty surface at the base. The physician highly suspects underlying osteomyelitis.

Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for the standard medical management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first perform plain radiography, followed by MRI of the foot, then obtain a bone biopsy off antibiotics, and finally initiate targeted antimicrobial therapy.
In a clinically stable, afebrile patient with a chronic diabetic foot ulcer and positive probe-to-bone testing, the management sequence prioritizes accurate diagnosis and pathogen identification over immediate medical therapy. Plain radiography is the mandatory initial test. Because it may lack sensitivity in early or indolent disease, MRI follows to confirm the diagnosis and delineate the anatomical extent. Subsequently, a bone biopsy is required as the gold standard for diagnosis. Critically, in patients without systemic signs of sepsis or severe acute cellulitis, empiric broad-spectrum antibiotics should be strictly withheld until the bone biopsy is obtained. Once cultures confirm the organism, prolonged, targeted systemic antimicrobial therapy can be initiated.

Step-by-Step Solution

1
Perform plain radiography of the affected foot.
Evaluates the foot for baseline gross bony changes, cortical destruction, soft tissue gas, or radiopaque foreign bodies.
Due to its wide availability and low cost, plain radiography is always the initial imaging test of choice for suspected osteomyelitis, even though it may appear normal during the first 2 weeks of infection.
2
Perform magnetic resonance imaging (MRI) of the foot.
Identifies early bone marrow edema and defines the exact anatomical extent of the infection.
MRI is the most sensitive and specific imaging test for osteomyelitis. It maps the infection to guide the subsequent surgical or percutaneous biopsy site.
3
Obtain a bone biopsy for microbiological culture.
Yields a definitive microbiologic diagnosis and histopathologic confirmation of osteomyelitis.
Because diabetic foot infections are often polymicrobial, a bone culture is the gold standard. In hemodynamically stable patients without severe acute cellulitis, this must be done BEFORE giving antibiotics to maximize culture yield.
4
Initiate targeted systemic antimicrobial therapy.
Treats the infection using narrow-spectrum agents proven to be effective against the isolated organism.
Chronic osteomyelitis requires a prolonged course of antibiotics (typically 6 weeks). Therapy should be strictly tailored to biopsy susceptibilities to ensure efficacy and promote antibiotic stewardship.

Key Concept

In hemodynamically stable patients with chronic diabetic foot osteomyelitis, empiric antibiotics must be withheld until after imaging and a definitive bone biopsy are obtained to ensure accurate microbiologic diagnosis.

Alternative Method

In cases where MRI is contraindicated (e.g., incompatible pacemakers), a Ceretec (WBC) scan combined with a bone scan may be used as the alternative advanced imaging step before biopsy.
Estimated Time:2m 0s
Question 404Question →

A 58-year-old man is brought to the emergency department by his wife due to fever, severe headache, and confusion that started 12 hours ago. His wife reports that he has also been dragging his right leg since the onset of symptoms. His temperature is 39.2°C (102.6°F), blood pressure is 145/90 mm Hg, and pulse is 110/min. Physical examination reveals marked nuchal rigidity and right-sided hemiparesis. He is lethargic but arouses to verbal stimuli. Arrange the following management steps in the most appropriate chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: obtain blood cultures, administer intravenous dexamethasone and empiric antibiotics, perform a non-contrast CT scan of the head, and perform a lumbar puncture.
In a patient with suspected bacterial meningitis and focal neurologic deficits (hemiparesis), a CT scan of the head is required before a lumbar puncture to avoid brain herniation. Because these procedures take time, life-saving therapy cannot be delayed. Therefore, blood cultures must be drawn immediately, followed promptly by empiric antibiotics and dexamethasone. Once therapy is initiated, the CT scan is performed, and if it is safe, the lumbar puncture is conducted.

Step-by-Step Solution

1
Identify indications for neuroimaging prior to lumbar puncture.
The patient's right-sided hemiparesis is identified as a focal neurologic deficit.
Focal deficits, altered mental status, papilledema, new-onset seizures, or an immunocompromised state require a CT scan before a lumbar puncture to rule out mass effect and prevent brain herniation.
2
Determine the first step in managing suspected bacteremia or meningitis.
Blood cultures must be drawn immediately.
Drawing blood cultures before antibiotic administration ensures the best chance of isolating the pathogen, and this step does not significantly delay life-saving therapy.
3
Determine the timing of empiric antimicrobial therapy.
Intravenous dexamethasone and empiric antibiotics are administered next.
When a CT scan is required, therapy cannot be delayed until after the imaging and lumbar puncture are completed. Dexamethasone must be given with or just before the antibiotics.
4
Sequence the remaining diagnostic procedures.
Perform the CT scan of the head, followed by the lumbar puncture.
The CT scan must confirm safety before the lumbar puncture is performed to obtain cerebrospinal fluid for definitive diagnosis.

Key Concept

Management sequence for suspected bacterial meningitis with indications for a head CT before lumbar puncture.
Question 405Question →

A 68-year-old man is evaluated in the intensive care unit on his fifth day of mechanical ventilation. He originally presented with severe acute pancreatitis complicated by acute respiratory distress syndrome. Three days ago, he developed a temperature of 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), increased purulent endotracheal secretions, and a new right lower lobe infiltrate on chest radiograph. He was diagnosed with ventilator-associated pneumonia and empirically started on intravenous vancomycin, cefepime, and tobramycin. Today, his temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}), and his oxygen requirements have decreased. The endotracheal aspirate culture from three days ago grows heavy growth (>105 CFU/mL>10^5\text{ CFU/mL}) of *Klebsiella pneumoniae*. Susceptibility testing reveals resistance to ampicillin, but susceptibility to ceftriaxone, cefepime, piperacillin-tazobactam, and meropenem. Blood cultures are negative. Which of the following is the most appropriate next step in this patient's antimicrobial management?

Show answer & explanation

Answer: Discontinue vancomycin and tobramycin; change cefepime to intravenous ceftriaxone

Answer

The most appropriate step is to discontinue vancomycin and tobramycin, and change cefepime to intravenous ceftriaxone.
The correct answer demonstrates proper antimicrobial stewardship through de-escalation. The patient was appropriately started on a broad-spectrum empiric regimen (vancomycin for MRSA, cefepime and tobramycin for double anti-pseudomonal coverage) for ventilator-associated pneumonia. Now that the patient is clinically improving and culture data reveals a single pathogen (*Klebsiella pneumoniae*) that is susceptible to standard beta-lactams, the empiric regimen must be narrowed. Vancomycin and tobramycin should be discontinued because neither MRSA nor *Pseudomonas aeruginosa* was isolated. Among the susceptible beta-lactams, ceftriaxone is a third-generation cephalosporin with excellent activity against wild-type *Klebsiella pneumoniae* but lacks anti-pseudomonal activity. It is the narrowest effective agent listed. Transitioning from cefepime (a fourth-generation cephalosporin with anti-pseudomonal activity) to ceftriaxone is the optimal stewardship intervention.

Step-by-Step Solution

1
Evaluate the clinical trajectory and need for continued empiric therapy.
The patient's fever has resolved and oxygenation has improved, indicating clinical stability and appropriateness for antimicrobial de-escalation.
De-escalation should be performed once a patient is clinically improving and culture data becomes available.
2
Interpret the culture and susceptibility results.
The pathogen is Klebsiella pneumoniae, susceptible to multiple beta-lactams but not ampicillin. There is no MRSA or Pseudomonas aeruginosa present.
Identifying the specific pathogen allows for discontinuation of agents covering organisms not present in the culture.
3
Apply principles of antimicrobial stewardship to select definitive therapy.
Vancomycin (MRSA coverage) and tobramycin (double Gram-negative/Pseudomonal coverage) must be stopped. Cefepime must be narrowed.
Maintaining unnecessary broad-spectrum agents increases the risk of adverse effects and antimicrobial resistance.
4
Select the narrowest effective agent for the identified organism.
Ceftriaxone is chosen over cefepime, piperacillin-tazobactam, and meropenem.
Ceftriaxone provides targeted therapy for wild-type Klebsiella pneumoniae without exerting selective pressure for Pseudomonas or anaerobic resistance.

Key Concept

Antimicrobial stewardship dictates that empiric broad-spectrum therapy for hospital-acquired infections should be narrowed to the most targeted, definitive agent once culture and susceptibility data are available and clinical improvement is noted.
Estimated Time:2m 0s
Question 406Question →

A 71-year-old man is evaluated on the medical ward on hospital day 3. He was initially admitted for severe community-acquired pneumonia presenting with fever, productive cough, hypoxemia, and a dense left lower lobe consolidation on a chest radiograph. At the time of admission, empiric therapy with intravenous ceftriaxone and oral azithromycin was initiated. He has shown excellent clinical improvement; his oxygen requirements have resolved, and he has been afebrile for the past 24 hours. The patient is currently tolerating a regular diet and ambulating in the hallways. Both blood and high-quality sputum cultures obtained on admission have finalized, demonstrating the growth of *Streptococcus pneumoniae*. Susceptibility testing results for the isolate are as follows:

Antimicrobial AgentInterpretationMinimum Inhibitory Concentration (MIC)
PenicillinSusceptible0.030.03 µg/mL
AmoxicillinSusceptible≤1.0\le 1.0 µg/mL
CeftriaxoneSusceptible0.250.25 µg/mL
LevofloxacinSusceptible0.50.5 µg/mL
AzithromycinResistant>8.0> 8.0 µg/mL

The patient is being prepared for discharge with a prescription to complete a 7-day total course of antibiotics. Which of the following is the most appropriate antibiotic regimen for this patient's discharge?

Show answer & explanation

Answer: Oral amoxicillin

Answer

Oral amoxicillin
The correct response identifies that the patient requires de-escalation of his antibiotic regimen. He initially received standard empiric therapy (ceftriaxone and azithromycin) for inpatient community-acquired pneumonia. With the pathogen identified as a penicillin-susceptible strain of *Streptococcus pneumoniae*, and the patient clinically stable and tolerating oral intake, the most appropriate next step is to transition to a narrow-spectrum oral agent. High-dose oral amoxicillin effectively treats this infection while strictly adhering to antimicrobial stewardship principles.

Step-by-Step Solution

1
Identify the primary pathogen and analyze its susceptibility profile from the provided laboratory data.
The pathogen is Streptococcus pneumoniae, which is susceptible to penicillin (and amoxicillin), ceftriaxone, and levofloxacin, but resistant to azithromycin.
Determining the specific etiology and resistance pattern is required to tailor ongoing antimicrobial therapy away from empiric regimens.
2
Evaluate the patient's clinical trajectory to determine the appropriate route of administration (intravenous vs. oral).
The patient is clinically improved, afebrile, hemodynamically stable, and tolerating an oral diet, indicating he is ready for transition to oral therapy.
Early transition from intravenous to oral therapy reduces catheter-related complications, shortens hospital length of stay, and decreases healthcare costs.
3
Select the most appropriate oral agent based on the principles of antimicrobial stewardship.
Oral amoxicillin is the optimal choice because it provides highly effective, targeted, narrow-spectrum coverage against this specific isolate.
Using the narrowest effective spectrum minimizes collateral damage to the host microbiome and reduces the selection pressure that drives antimicrobial resistance.

Key Concept

De-escalation of empiric broad-spectrum antibiotic therapy to a targeted, narrow-spectrum agent (e.g., oral amoxicillin) is the standard of care for clinically stable patients with penicillin-susceptible Streptococcus pneumoniae pneumonia.
Estimated Time:1m 0s
Question 407Question →

A patient receiving cytotoxic chemotherapy for acute myeloid leukemia arrives at the oncology triage unit reporting severe chills and a recorded temperature of 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}). Her blood pressure is 100/60 mm Hg100/60\text{ mm Hg}, and her heart rate is 112/min112/\text{min}. She has an indwelling totally implantable venous access device. Laboratory analysis reveals an absolute neutrophil count of 350/mm3350/\text{mm}^3.

Arrange the following interventions in the most appropriate sequential order for managing this patient's condition according to standard clinical guidelines for high-risk febrile neutropenia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Obtain blood cultures, administer empiric antipseudomonal beta-lactam therapy, reassess clinical response at 48-72 hours, and finally add empiric antifungal therapy if fever persists after 4-7 days.
High-risk febrile neutropenia is an infectious disease emergency. The standard sequence of care dictates immediately drawing blood cultures to identify the pathogen, followed promptly (within 60 minutes) by empiric broad-spectrum antibiotics with antipseudomonal activity. Once stabilized, the patient is reassessed at 48 to 72 hours when preliminary microbiological data is available. If the patient remains persistently febrile and profoundly neutropenic for 4 to 7 days despite appropriate antibacterial therapy, an occult invasive fungal infection is highly suspected, warranting the sequential addition of empiric antifungal coverage.

Step-by-Step Solution

1
Identify the clinical emergency
The patient has high-risk febrile neutropenia (absolute neutrophil count < 500/mm3500/\text{mm}^3 and fever).
Recognizing the condition dictates the extreme urgency of diagnostic and therapeutic interventions.
2
Prioritize initial diagnostic testing
Blood cultures are drawn from both the central port and a peripheral site as the first active intervention.
Crucial to capture the pathogen before antibacterial agents alter microbiological viability.
3
Initiate empiric pharmacotherapy
Intravenous antipseudomonal beta-lactam therapy is administered immediately after cultures are drawn.
Delays in antibiotic administration significantly increase mortality in neutropenic patients; it is a time-sensitive emergency.
4
Plan sequential follow-up and escalation
Reassessment occurs at 48 to 72 hours, with potential addition of empiric antifungals at 4 to 7 days if fever persists.
Aligns with expected microbiological turnaround times and the known timeline for secondary invasive fungal infections.

Key Concept

Chronological management of high-risk febrile neutropenia
Question 408Question →

A 25-year-old medical student is reviewing post-exposure prophylaxis protocols for various infectious disease scenarios. Which prophylactic regimen is most appropriate for each of the following patient exposures?

Click a left item, then click its matching right item

Items

Adult with an Ixodes tick attached for 48 hours in an endemic region, currently asymptomatic.
Healthcare worker with a deep percutaneous needlestick injury from a patient with untreated HIV.
Asymptomatic adult who shares a dormitory room with a patient recently diagnosed with meningococcal meningitis.
Unvaccinated adult presenting with a deep, soil-contaminated puncture wound to the foot.
Previously unvaccinated traveler who sustained an unprovoked bat bite while exploring a cave.

Matches

Show answer & explanation

Answer

The correct matches align specific infectious exposures with their targeted prophylactic guidelines: Lyme disease exposure requires single-dose doxycycline; HIV requires a 3-drug ART regimen for four weeks; meningococcal exposure requires single-dose ciprofloxacin; a tetanus-prone wound in an unvaccinated patient requires vaccine plus immunoglobulin; and a rabies exposure in an unvaccinated patient requires vaccine plus immunoglobulin.
Each clinical scenario presents a high-risk infectious exposure that warrants immediate, targeted post-exposure prophylaxis to prevent disease transmission or activation. The matching pairs reflect current standard-of-care guidelines for Lyme disease, HIV, meningococcal disease, tetanus, and rabies.

Step-by-Step Solution

1
Analyze the mechanism of exposure and the suspected pathogen.
Pathogens identified: Borrelia burgdorferi, HIV, Neisseria meningitidis, Clostridium tetani, and Rabies virus.
Accurate pathogen identification dictates the specific prophylactic agent required.
2
Assess the patient's baseline immune status or symptom profile in the vignette.
Patients are noted as asymptomatic, unvaccinated, or immunologically naive to the specific pathogen.
Vaccination status determines whether passive immunization (immunoglobulins) must be added to active immunization.
3
Select the guideline-concordant preventive regimen.
Appropriate antimicrobials or immunizations are assigned to each high-risk exposure.
Following current post-exposure prophylaxis guidelines minimizes the risk of progression to active clinical disease.

Key Concept

Post-Exposure Prophylaxis (PEP) in Infectious Diseases
Estimated Time:2m 0s
Question 409Question →

During bedside rounds on the medical ward, the care team evaluates a 28-year-old woman who is currently on her third day of hospitalization for acute pyelonephritis. At the time of admission, she reported right-sided flank pain, nausea, and subjective fevers, prompting the initiation of empiric intravenous ceftriaxone. Her symptoms have now completely resolved, and she has been tolerating a regular diet since yesterday evening. Vital signs are temperature 37.1°C (98.8°F), blood pressure 118/76 mm Hg, pulse 78/min, and respirations 14/min. The urine culture collected on admission has finalized, demonstrating >105> 10^5 CFU/mL of *Escherichia coli*. Antimicrobial susceptibility testing indicates that the isolate is resistant to ampicillin and ciprofloxacin, but is susceptible to ceftriaxone, trimethoprim-sulfamethoxazole, nitrofurantoin, and meropenem. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Transition to oral trimethoprim-sulfamethoxazole

Answer

Transition to oral trimethoprim-sulfamethoxazole
The correct action is to transition the patient to oral trimethoprim-sulfamethoxazole. The patient's clinical improvement (resolution of fever and pain, ability to tolerate oral intake) indicates she is ready for intravenous-to-oral step-down therapy. Among the susceptible options, trimethoprim-sulfamethoxazole is the optimal choice as it possesses high oral bioavailability and achieves excellent therapeutic concentrations within the renal parenchyma to successfully treat acute pyelonephritis.

Step-by-Step Solution

1
Assess the patient's clinical trajectory and readiness for step-down therapy.
The patient is afebrile, her flank pain has resolved, and she is tolerating a regular diet.
Clinical stability dictates the timing for transitioning from intravenous to oral antimicrobial therapy to facilitate hospital discharge and reduce catheter-related risks.
2
Analyze the antimicrobial susceptibility profile of the isolated pathogen.
The E. coli isolate is susceptible to ceftriaxone, trimethoprim-sulfamethoxazole, and nitrofurantoin, but resistant to ampicillin and ciprofloxacin.
Targeted oral therapy must be guided by in vitro susceptibility to ensure successful eradication of the infection.
3
Select the most appropriate oral agent that achieves therapeutic concentrations in the affected tissue.
Oral trimethoprim-sulfamethoxazole is chosen over nitrofurantoin.
Trimethoprim-sulfamethoxazole penetrates the renal parenchyma effectively. Nitrofurantoin only concentrates in the bladder and is inadequate for upper urinary tract infections like pyelonephritis.

Key Concept

Intravenous to oral antimicrobial transition in pyelonephritis and the pharmacokinetic limitations of nitrofurantoin.
Question 410Question →

Correlate the following clinical scenarios involving suspected central nervous system infections with the most appropriate empiric or targeted pharmacotherapy.

Click a left item, then click its matching right item

Items

A 72-year-old female with hypertension arrives at the emergency department with acute high fever, photophobia, and stiff neck. Lumbar puncture demonstrates neutrophilic pleocytosis and hypoglycorrhachia.
A 32-year-old male with an absolute CD4 count of 35 cells/mm335 \text{ cells/mm}^3 experiences subacute confusion and lethargy. Cerebrospinal fluid analysis reveals a mononuclear pleocytosis and an opening pressure of 320 mm H2O320 \text{ mm H}_2\text{O}.
A 28-year-old forestry worker reports left-sided facial weakness and a severe headache. He recalls an erythematous expanding rash on his leg four weeks prior. Cerebrospinal fluid shows lymphocytic pleocytosis.
A 45-year-old male is brought in by family due to rapidly progressive disorientation, fever, and olfactory hallucinations. Brain imaging shows unilateral temporal lobe edema, and cerebrospinal fluid contains elevated erythrocytes.
A 40-year-old female recovering on postoperative day five from a craniotomy for a benign meningioma develops high fever and nuchal rigidity. Cerebrospinal fluid analysis demonstrates significant neutrophilic pleocytosis.

Matches

Show answer & explanation

Answer

1: Empiric bacterial meningitis >50 years is treated with ceftriaxone, vancomycin, and ampicillin. 2: Cryptococcal meningitis is treated with liposomal amphotericin B and flucytosine. 3: Neurologic Lyme disease is treated with intravenous ceftriaxone. 4: HSV encephalitis is treated with intravenous acyclovir. 5: Post-neurosurgical meningitis is treated with vancomycin and cefepime.
Each clinical scenario uniquely points to a distinct central nervous system infection etiology requiring a specific therapeutic approach based on current Infectious Diseases Society of America (IDSA) guidelines.

Step-by-Step Solution

1
Analyze each patient's demographic profile, exposure history, and immune status.
Identified a healthy older adult, a severely immunocompromised HIV patient, an outdoor worker with a previous erythema migrans rash, an adult with rapidly progressive encephalopathy, and a post-neurosurgical patient.
Host factors and epidemiologic exposures dictate the most likely etiology of central nervous system infections.
2
Evaluate the localized signs and cerebrospinal fluid (CSF) findings.
Correlated neutrophilic pleocytosis with bacterial meningitis, mononuclear pleocytosis with elevated pressure to fungal/cryptococcal infection, hemorrhagic CSF with temporal lobe edema to HSV, and lymphocytic pleocytosis with facial palsy to neurologic Lyme.
CSF profiles (neutrophilic vs. lymphocytic/mononuclear) and imaging findings help differentiate bacterial, viral, fungal, and spirochetal causes.
3
Select the guideline-recommended antimicrobial regimen for each specific diagnosis.
Matched age-based bacterial coverage, targeted fungal induction therapy, anti-spirochetal cephalosporin therapy, antiviral therapy, and anti-pseudomonal/MRSA coverage accordingly.
Delivering precise empiric or targeted therapy prevents significant morbidity and mortality associated with central nervous system infections.

Key Concept

Selection of empiric and targeted antimicrobial regimens for central nervous system infections must be strictly tailored to patient age, immune status, unique exposures, and specific cerebrospinal fluid profiles.
Question 411Question →

A 32-year-old man presents to the emergency department with a 4-week history of productive cough, occasional hemoptysis, low-grade fevers, and night sweats. He has experienced a 5-kg (11-lb) unintentional weight loss during this time. The patient immigrated to the United States from a region highly endemic for tuberculosis two months ago. His temperature is 37.8°C (100.0°F), blood pressure is 120/78 mm Hg, pulse is 88/min, and respiratory rate is 16/min. Physical examination reveals bronchial breath sounds and crackles in the right upper lung field. The clinical presentation is highly suspicious for active pulmonary tuberculosis. Arrange the following management steps in the most appropriate chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of steps is: 1) Place the patient in an airborne infection isolation room with negative pressure, 2) Obtain a posterior-anterior and lateral chest radiograph, 3) Obtain sputum specimens for acid-fast bacilli smear and culture, and 4) Initiate empiric four-drug therapy with rifampin, isoniazid, pyrazinamide, and ethambutol.
The proper sequence for managing a patient with high clinical suspicion for active pulmonary tuberculosis begins with protecting public health. Immediate airborne infection isolation is the absolute first priority. Once the patient is isolated, the diagnostic workup begins with a chest radiograph to identify characteristic pulmonary lesions. This is followed by the collection of sputum specimens for definitive microbiologic diagnosis. Finally, empiric anti-mycobacterial therapy is initiated only after all diagnostic cultures have been collected, ensuring the medications do not interfere with culture yield.

Step-by-Step Solution

1
Assess the risk of airborne transmission.
The patient's symptoms (chronic cough, hemoptysis, weight loss) and epidemiologic history strongly suggest active tuberculosis.
Identifying the high risk of a highly contagious airborne disease dictates the immediate need for strict infection control.
2
Implement immediate infection control measures.
The patient is placed in an airborne infection isolation room.
To prevent the aerosolized spread of Mycobacterium tuberculosis to healthcare personnel and other patients in the emergency department.
3
Perform initial diagnostic imaging.
A chest radiograph is obtained (often via portable machine).
To rapidly evaluate for structural lung abnormalities indicative of tuberculosis, such as apical consolidations or cavitations.
4
Secure definitive microbiologic diagnostic samples.
Sputum specimens are collected for AFB smear, culture, and nucleic acid amplification testing.
To confirm the diagnosis microbiologically and obtain crucial drug susceptibility testing prior to introducing medications.
5
Initiate empiric targeted pharmacotherapy.
A four-drug regimen (RIPE) is started.
To begin treating the active infection safely after all necessary diagnostic samples have been securely obtained.

Key Concept

Management Sequence for Suspected Active Pulmonary Tuberculosis
Estimated Time:1m 30s
Question 412Question →

A 29-year-old man is evaluated in the hospital for ongoing fever. He was admitted 4 days ago with high fevers, chills, and pleuritic chest pain. His medical history is significant for opioid use disorder with active intravenous heroin use. On admission, his temperature was 39.2°C (102.6°F). Physical examination revealed a new holosystolic murmur at the lower left sternal border. Computed tomography of the chest showed multiple peripheral cavitary lesions. Two sets of blood cultures were drawn, and he was started on empiric intravenous vancomycin and ceftriaxone. A transthoracic echocardiogram demonstrated a 1.5-cm mobile vegetation on the anterior leaflet of the tricuspid valve. Today, the patient's temperature is 38.4°C (101.1°F). The admission blood cultures are now growing methicillin-susceptible *Staphylococcus aureus* (MSSA). Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Discontinue current antibiotics and start intravenous cefazolin

Answer

Discontinue current antibiotics and start intravenous cefazolin
The correct answer requires recognizing that for severe, invasive infections caused by methicillin-susceptible Staphylococcus aureus (MSSA), antistaphylococcal beta-lactams (such as cefazolin, nafcillin, or oxacillin) are the superior treatment choice. Although vancomycin is an appropriate initial empiric choice to cover potential MRSA, it has slower bactericidal activity against MSSA compared to beta-lactams. Continuing vancomycin once MSSA is confirmed is associated with prolonged bacteremia, higher rates of treatment failure, and increased mortality. Therefore, the most appropriate next step in antibiotic stewardship and patient management is to discontinue both the vancomycin and the ceftriaxone (which was covering gram-negatives) and initiate targeted therapy with intravenous cefazolin.

Step-by-Step Solution

1
Identify the primary diagnosis based on the clinical presentation
The patient has native valve right-sided infective endocarditis complicated by septic pulmonary emboli.
The combination of intravenous drug use, a new tricuspid regurgitation murmur, cavitary lung lesions, a large tricuspid vegetation, and positive blood cultures confirms the diagnosis.
2
Evaluate the current empiric antibiotic regimen against the culture results
The patient is receiving empiric vancomycin and ceftriaxone, but the pathogen is identified as methicillin-susceptible Staphylococcus aureus (MSSA).
Broad-spectrum empiric therapy must be narrowed and optimized once the exact pathogen and its susceptibilities are identified.
3
Determine the optimal targeted pharmacotherapy for the identified pathogen
Therapy should be de-escalated to an intravenous antistaphylococcal beta-lactam, such as cefazolin, nafcillin, or oxacillin.
Beta-lactams provide superior bactericidal activity, faster clearance of bacteremia, and significantly improved survival rates compared to vancomycin for MSSA endovascular infections.

Key Concept

De-escalation of empiric therapy to an antistaphylococcal beta-lactam (e.g., cefazolin, nafcillin) is the standard of care for methicillin-susceptible Staphylococcus aureus (MSSA) endocarditis, as beta-lactams are clinically superior to vancomycin for MSSA.
Question 413Question →

Select the most appropriate first-line antimicrobial therapy for each of the following patients presenting with a characteristic infectious syndrome.

Click a left item, then click its matching right item

Items

A 34-year-old patient presenting with an expanding 8-cm annular erythematous rash with central clearing on the thigh after a recent camping trip.
A 22-year-old patient presenting with acute dysuria, urinary frequency, and suprapubic discomfort, with no fever or costovertebral angle tenderness.
A 55-year-old patient presenting with a rapidly spreading, poorly demarcated, warm, tender area of erythema on the lower leg without purulent drainage.
A 30-year-old patient presenting with a single 1-cm painless, indurated anogenital ulcer with a clean base and non-tender inguinal lymphadenopathy.

Matches

Show answer & explanation

Answer

The correct matches pair early localized Lyme disease with oral doxycycline, uncomplicated cystitis with oral nitrofurantoin, non-purulent cellulitis with oral cephalexin, and primary syphilis with intramuscular benzathine penicillin G.
Each specific clinical vignette describes a hallmark presentation of a common outpatient infection, each with a highly standardized first-line treatment pathway. Recognizing erythema migrans directs the clinician to doxycycline; uncomplicated dysuria directs to nitrofurantoin; non-purulent skin erythema directs to a first-generation cephalosporin like cephalexin; and a painless genital chancre strictly mandates benzathine penicillin G.

Step-by-Step Solution

1
Evaluate the first presentation.
Diagnose early localized Lyme disease based on the classic erythema migrans rash.
Identifying the disease allows for the selection of the correct first-line therapy, which is oral doxycycline.
2
Evaluate the second presentation.
Diagnose uncomplicated acute cystitis due to the presence of lower urinary tract symptoms without systemic signs.
Nitrofurantoin is first-line because it concentrates effectively in the urine and avoids unnecessarily broad systemic coverage.
3
Evaluate the third presentation.
Diagnose non-purulent cellulitis based on the rapidly spreading erythema without an abscess or purulence.
Oral cephalexin is selected as it provides optimal coverage against beta-hemolytic streptococci and methicillin-susceptible Staphylococcus aureus (MSSA).
4
Evaluate the fourth presentation.
Diagnose primary syphilis based on the single painless genital chancre.
Intramuscular benzathine penicillin G is the definitive treatment for all stages of syphilis (unless neurosyphilis is present).

Key Concept

First-line empiric and targeted antimicrobial selection for classic outpatient infectious syndromes.
Question 414Question →

A 68-year-old man comes to the clinic reporting the onset of frequent, watery, non-bloody diarrhea occurring up to 77 times daily over the past 33 days. He also notes mild, diffuse lower abdominal cramping. His medical history is significant for hypertension and hyperlipidemia. Two weeks ago, he completed a 10-day course of oral amoxicillin-clavulanate for acute bacterial sinusitis. His temperature is 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}), blood pressure is 118/76 mmHg118/76 \text{ mmHg}, and heart rate is 92/min92/\text{min}. Physical examination reveals mild diffuse abdominal tenderness with normal bowel sounds; there is no guarding or rebound tenderness. Laboratory testing shows a leukocyte count of 14,500/mm314,500/\text{mm}^3 and a serum creatinine of 1.1 mg/dL1.1 \text{ mg/dL} (baseline 1.0 mg/dL1.0 \text{ mg/dL}). A stool nucleic acid amplification test is positive for *Clostridioides difficile* toxin genes. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer oral fidaxomicin

Answer

The correct approach is to administer oral fidaxomicin.
The most appropriate next step in management is the administration of oral fidaxomicin. This patient is presenting with an initial episode of *Clostridioides difficile* infection (CDI), likely precipitated by his recent course of amoxicillin-clavulanate. According to updated guidelines from the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA), oral fidaxomicin is the preferred first-line therapy for both non-severe and severe initial episodes of CDI. Oral vancomycin is an acceptable alternative. Fidaxomicin is preferred over vancomycin because it has a narrower spectrum of activity (preserving normal gut flora) and has been shown to result in lower rates of CDI recurrence.

Step-by-Step Solution

1
Identify the primary diagnosis based on the clinical presentation.
The patient has an initial episode of Clostridioides difficile infection (CDI).
The diagnosis is supported by the history of recent antibiotic use, acute watery diarrhea, and a positive stool nucleic acid amplification test for C. difficile toxins.
2
Assess the severity of the CDI episode.
This is a non-severe episode.
The patient is hemodynamically stable without signs of fulminant disease. Furthermore, the leukocyte count is less than 15,000/mm315,000/\text{mm}^3 and serum creatinine is less than 1.5 mg/dL1.5 \text{ mg/dL}.
3
Determine the most appropriate pharmacotherapy based on current guidelines.
Select oral fidaxomicin (or oral vancomycin).
Current Infectious Diseases Society of America (IDSA) guidelines recommend oral fidaxomicin as the preferred first-line agent for initial CDI (both non-severe and severe) to maximize clinical cure and reduce the risk of recurrence.

Key Concept

First-line pharmacotherapy for an initial episode of Clostridioides difficile infection.
Question 415Question →

A 54-year-old man with a history of poorly controlled HIV (most recent CD4 count 112 cells/mm³) is brought to the emergency department by his partner due to fever, severe headache, and confusion over the past 24 hours. His temperature is 39.1°C (102.4°F), blood pressure is 110/70 mm Hg, pulse is 112/min, and respiratory rate is 18/min. Physical examination reveals nuchal rigidity and a new right-sided pronator drift. The physician suspects acute bacterial meningitis. Arrange the following steps in the most appropriate chronological sequence for the management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Obtain blood cultures, 2) Administer empiric intravenous antibiotics and dexamethasone, 3) Perform a noncontrast CT scan of the head, 4) Perform a lumbar puncture.
In the management of suspected acute bacterial meningitis, the primary goal is rapid initiation of antimicrobial therapy. While a lumbar puncture (LP) should ideally be performed before giving antibiotics, certain patients require a head CT prior to LP to rule out mass effect and prevent brain herniation. Indications for CT before LP include an immunocompromised state (e.g., HIV), history of CNS disease, new-onset seizure, papilledema, altered level of consciousness, and focal neurologic deficits. Because obtaining a CT scan delays the LP, blood cultures must be drawn immediately, followed by the administration of empiric intravenous antibiotics and dexamethasone. Once therapy is initiated, the patient can safely undergo the CT scan, followed by the LP.

Step-by-Step Solution

1
Obtain blood cultures
Pathogen isolation is optimized prior to the introduction of systemic antimicrobials.
Administering antibiotics before drawing cultures can sterilize the blood, making targeted therapy difficult.
2
Administer empiric intravenous antibiotics and dexamethasone
Immediate treatment of the suspected central nervous system infection begins.
Delays in therapy drastically increase mortality. When a CT scan is required prior to a lumbar puncture, antimicrobials must be administered immediately after blood cultures are drawn.
3
Perform a noncontrast CT scan of the head
Intracranial mass effect or shift is evaluated.
This patient has indications for pre-LP neuroimaging: an immunocompromised state (HIV) and a focal neurologic abnormality (pronator drift).
4
Perform a lumbar puncture
Cerebrospinal fluid is obtained for Gram stain, culture, cell count, and protein/glucose levels.
Once mass effect is ruled out by the CT scan, it is safe to perform the procedure without risking fatal brain herniation.

Key Concept

Management sequence for suspected bacterial meningitis when neuroimaging is indicated prior to lumbar puncture.
Question 416Question →

A primary care physician evaluates a 45-year-old woman who noticed an expanding area of redness on her right shin that began 48 hours ago. The affected region is tender to the touch, and she reports feeling mildly fatigued but denies chills, nausea, or recent trauma. Medical history is notable only for mild allergic rhinitis, for which she takes over-the-counter cetirizine. Her temperature is 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}), blood pressure is 122/78 mmHg122/78 \text{ mmHg}, pulse is 84/min84/\text{min}, and respiratory rate is 14/min14/\text{min}. Physical examination reveals a 10×6 cm10 \times 6 \text{ cm} erythematous, warm, and swollen plaque on the anterior right lower leg. The margins are indistinct. There is no palpable fluctuance, purulent exudate, or ulceration. Tender right inguinal lymphadenopathy is present. Which of the following is the most appropriate initial pharmacotherapy for this patient?

Show answer & explanation

Answer: Oral cephalexin

Answer

Oral cephalexin
The correct answer is oral cephalexin. The patient presents with classic signs of uncomplicated, non-purulent cellulitis (erythema, warmth, edema, and tenderness without a purulent exudate or fluctuance). The primary pathogens responsible for this condition are beta-hemolytic streptococci (especially Group A strep) and methicillin-susceptible Staphylococcus aureus (MSSA). Oral cephalexin, a first-generation cephalosporin, provides excellent targeted coverage for these organisms and is a standard first-line outpatient therapy. In accordance with antibiotic stewardship, MRSA coverage is not routinely indicated for non-purulent cellulitis unless the patient has systemic toxicity, prior episodes of MRSA infection, or other significant risk factors.

Step-by-Step Solution

1
Analyze the clinical presentation.
The patient has a well-demarcated, warm, erythematous, and tender plaque without fluctuance or purulence, consistent with uncomplicated non-purulent cellulitis.
Differentiating purulent from non-purulent skin infections dictates the likely pathogens and guides empiric antibiotic selection.
2
Identify the most likely causative organisms.
Non-purulent cellulitis is predominantly caused by beta-hemolytic streptococci (e.g., Streptococcus pyogenes) and methicillin-susceptible Staphylococcus aureus (MSSA).
Targeting the correct organism spectrum prevents treatment failure and avoids overly broad antibiotic use.
3
Select the appropriate pharmacotherapy.
An oral beta-lactam such as cephalexin or dicloxacillin is the treatment of choice, providing excellent coverage against the primary pathogens.
In the absence of systemic toxicity, purulence, or high risk for MRSA, narrow-spectrum oral therapy is indicated in accordance with antibiotic stewardship guidelines.

Key Concept

Uncomplicated, non-purulent cellulitis should be treated empirically with antibiotics that target beta-hemolytic streptococci and MSSA, such as oral cephalexin or dicloxacillin, avoiding unnecessary MRSA or broad-spectrum coverage.
Estimated Time:1m 0s
Question 417Question →

A 55-year-old man with a history of intravenous drug use comes to the emergency department reporting severe, unrelenting lower back pain for the past 3 weeks. The pain is worse at night, is not relieved by rest, and is accompanied by subjective fevers. He reports no leg weakness, numbness, or bowel and bladder incontinence. Temperature is 38.2°C (100.8°F), pulse is 92/min, and blood pressure is 128/78 mm Hg. Physical examination shows focal tenderness to percussion over the L4 and L5 spinous processes. Neurologic examination of the lower extremities reveals full strength, normal sensation, and intact reflexes bilaterally. Arrange the following steps in the most appropriate chronological sequence for the diagnostic workup and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Obtain blood cultures and inflammatory markers, 2) Perform an MRI of the lumbar spine, 3) Perform a CT-guided bone biopsy (if blood cultures are negative), and 4) Initiate targeted antibiotic therapy.
The proper management of native vertebral osteomyelitis in a neurologically stable patient prioritizes establishing a microbiologic diagnosis before initiating therapy. Blood cultures are drawn first as they are non-invasive and often diagnostic. MRI follows to confirm the extent of infection and rule out surgical emergencies like epidural abscess. If blood cultures are negative, a CT-guided bone biopsy is essential. Empiric antibiotics are deliberately withheld during this workup to prevent sterilizing the cultures, ensuring that the eventual long-term antibiotic course is appropriately targeted to the specific pathogen.

Step-by-Step Solution

1
Obtain blood cultures and inflammatory markers.
Establishes baseline inflammation and potentially identifies the pathogen non-invasively.
Blood cultures are rapid, non-invasive, and can preclude the need for a bone biopsy if they yield the causative organism.
2
Perform an MRI of the lumbar spine.
Confirms the diagnosis of vertebral osteomyelitis and evaluates the extent of infection.
MRI is the gold standard imaging test and is critical to rule out spinal epidural abscess or cord compression.
3
Perform a CT-guided needle biopsy if blood cultures are sterile.
Obtains infected tissue for definitive microbiologic culture and histopathology.
A precise microbiologic diagnosis is required. Empiric antibiotics must be withheld to avoid sterilizing this sample in neurologically stable patients.
4
Initiate targeted intravenous antibiotic therapy.
Provides definitive, pathogen-directed treatment.
Extended antibiotic therapy is tailored to the specific sensitivities of the identified organism to ensure efficacy and promote antimicrobial stewardship.

Key Concept

In neurologically stable patients with suspected native vertebral osteomyelitis, empiric antibiotics must be withheld until a microbiologic diagnosis is established via blood cultures or image-guided bone biopsy.
Question 418Question →

A 4141-year-old man is evaluated in the hospital on the third day of his admission for community-acquired pneumonia. He initially presented with a two-day history of high fever, productive cough, and right-sided pleuritic chest pain. On admission, his temperature was 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure was 118/74 mm Hg118/74\text{ mm Hg}, pulse was 110/min110\text{/min}, and respirations were 24/min24\text{/min}. Chest radiography showed a right lower lobe consolidation. He was subsequently started on empiric intravenous levofloxacin.

Today, the patient reports feeling significantly better. He has been afebrile for the past 24 hours24\text{ hours}, and his cough has improved. Current vital signs are temperature 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 122/78 mm Hg122/78\text{ mm Hg}, pulse 82/min82\text{/min}, and respirations 16/min16\text{/min}. He is tolerating a regular diet.

Blood cultures drawn on admission are now positive for Streptococcus pneumoniae. Susceptibility testing of the isolate demonstrates the following:

AntimicrobialInterpretation
PenicillinSusceptible
AmoxicillinSusceptible
CeftriaxoneSusceptible
LevofloxacinSusceptible
AzithromycinResistant

Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Transition to oral amoxicillin

Answer

Transition to oral amoxicillin
This patient has community-acquired pneumonia and has demonstrated significant clinical improvement, making him an excellent candidate for intravenous-to-oral antibiotic transition. Blood cultures grew Streptococcus pneumoniae that is susceptible to penicillin and amoxicillin. According to core principles of antibiotic stewardship, therapy should be narrowed from empiric broad-spectrum coverage (levofloxacin) to the most targeted effective agent once susceptibility data are available. Oral amoxicillin is the ideal narrow-spectrum agent for treating penicillin-susceptible S. pneumoniae.

Step-by-Step Solution

1
Assess the patient's clinical trajectory and criteria for IV to PO transition.
The patient is hemodynamically stable, afebrile for 24 hours, and tolerating an oral diet.
Establishing clinical stability confirms that the patient is ready to step down from intravenous to oral antibiotics.
2
Analyze the culture and susceptibility results.
The pathogen is Streptococcus pneumoniae, which is susceptible to penicillin and amoxicillin.
Identifying the specific organism and its susceptibility profile allows for targeted, pathogen-specific therapy rather than empiric broad-spectrum coverage.
3
Select the most appropriate antibiotic according to stewardship principles.
Oral amoxicillin is selected over oral levofloxacin, cefdinir, or amoxicillin-clavulanate.
Amoxicillin provides the most targeted, narrow-spectrum coverage for penicillin-susceptible S. pneumoniae, minimizing collateral damage to the patient's microbiome.

Key Concept

In patients hospitalized for community-acquired pneumonia, empiric broad-spectrum antibiotics should be de-escalated to the narrowest effective oral agent once clinical stability is achieved and culture/susceptibility data are available.
Question 419Question →

A 28-year-old medical resident sustains a deep percutaneous needle-stick injury to her hand while drawing blood from a patient in the emergency department. The source patient has a documented history of poorly controlled HIV with a high viral load. The hollow-bore needle was visibly contaminated with blood. What is the most appropriate chronological sequence of interventions for this occupational exposure?

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with immediate local decontamination, followed by baseline serologic evaluation, rapid initiation of three-drug antiretroviral post-exposure prophylaxis, and finally serial follow-up testing.
The established protocol for occupational exposure to HIV involves a sequential and rapid response. First, basic first aid must be administered by vigorously washing the wound with soap and water to decrease the viral load at the entry site. Following local wound care, baseline bloodwork must be drawn from the exposed healthcare worker to document their pre-exposure HIV, HBV, and HCV status. Immediately following the blood draw (and without waiting for the laboratory results), a 28-day course of a three-drug antiretroviral post-exposure prophylaxis (PEP) regimen should be initiated, as its efficacy heavily depends on administration within 1-2 hours of the exposure. Finally, the worker must undergo longitudinal serologic monitoring at regular intervals (typically 6 weeks, 12 weeks, and 6 months) to definitively rule out delayed seroconversion.

Step-by-Step Solution

1
Wash the wound with soap and water
Local decontamination
Reduces the viral inoculum at the site of the injury and is universally the immediate first step for any bodily fluid exposure.
2
Draw baseline laboratory tests from the healthcare worker
Documentation of baseline serostatus
Establishes whether the worker had a preexisting infection before post-exposure prophylaxis is started and before any potential seroconversion occurs.
3
Start three-drug antiretroviral PEP
Systemic viral suppression
Inhibits viral replication and integration. Must be given as rapidly as possible (ideally within 2 hours) for maximum prophylactic effect.
4
Schedule serial follow-up testing
Long-term monitoring
Ensures that the healthcare worker has not seroconverted after the prophylactic regimen is completed and the window period has passed.

Key Concept

Management of occupational HIV exposure (Post-Exposure Prophylaxis)
Estimated Time:1m 0s
Question 420Question →

An 8282-year-old woman is evaluated in the outpatient clinic for a routine follow-up. She is accompanied by her son, who assists with her activities of daily living. Her medical history is significant for type 2 diabetes mellitus, essential hypertension, and mild neurocognitive disorder. During the visit, the son expresses concern because he has noticed that the patient's urine in her bedside commode has appeared cloudy and distinctly malodorous over the last 7272 hours. He is worried she may have a urinary tract infection, as she was treated for one six months ago. Upon direct questioning, the patient is pleasant and conversant, remaining at her cognitive baseline. She explicitly denies experiencing any dysuria, increased urinary frequency, urinary urgency, flank pain, or subjective fevers. Her vital signs include a temperature of 37.1∘37.1^{\circ} C (98.8∘98.8^{\circ} F), blood pressure of 135/85135/85 mmHg, heart rate of 7878/min, and respiratory rate of 1414/min. Abdominal examination is soft and non-tender, with no suprapubic discomfort or costovertebral angle tenderness. A clean-catch urinalysis obtained in the clinic reveals positive leukocyte esterase, positive nitrites, and 3535 white blood cells per high-power field. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance and observation

Answer

The correct answer is reassurance and observation because the patient has asymptomatic bacteriuria, which does not require treatment in this population.
The correct approach is reassurance and observation because this patient's clinical presentation is classic for asymptomatic bacteriuria (ASB). ASB is defined as the presence of significant bacteriuria (and often pyuria) in the absence of localized urinary tract symptoms (such as dysuria, urgency, or frequency) or systemic signs of infection (such as fever or altered mental status). Cloudy and malodorous urine are common complaints but are not specific for an active infection and do not warrant treatment on their own. According to current infectious disease guidelines and antimicrobial stewardship principles, screening for and treating ASB is strictly limited to specific high-risk groups: pregnant patients, individuals undergoing urologic procedures with anticipated mucosal bleeding, and occasionally neutropenic patients. In all other populations—including the elderly, patients with diabetes mellitus, and those with indwelling catheters—treating ASB does not decrease the incidence of symptomatic infections or improve survival. Instead, unnecessary antibiotic exposure significantly increases the risk of adverse drug events, Clostridioides difficile infection, and the development of multidrug-resistant organisms.

Step-by-Step Solution

1
Evaluate the patient's clinical symptoms and presentation in conjunction with laboratory findings.
The patient has cloudy, malodorous urine and pyuria, but entirely lacks systemic symptoms (no fever, no altered mental status) or localized urinary tract symptoms (no dysuria, frequency, or urgency).
Differentiating a symptomatic urinary tract infection from asymptomatic bacteriuria relies heavily on the presence of clinical symptoms rather than laboratory findings alone.
2
Determine the indication for antibiotic therapy based on current clinical guidelines.
The clinical picture is consistent with asymptomatic bacteriuria. Screening and treatment are only indicated for pregnant women, patients undergoing urologic procedures with anticipated mucosal trauma, and select immunocompromised patients.
Treating asymptomatic bacteriuria in other populations, including the elderly and diabetic patients, does not improve clinical outcomes.
3
Select the appropriate management plan that aligns with antimicrobial stewardship.
No further diagnostic testing or antibiotic therapy is required; reassurance and observation are the indicated steps.
Antimicrobial stewardship dictates avoiding unnecessary antibiotics to prevent resistance and avoid complications such as adverse drug reactions or Clostridioides difficile infection.

Key Concept

Diagnosis and management of asymptomatic bacteriuria in the elderly
PreviousPage 21 / 26Next
Infectious Diseases Practice Questions — USMLE Step 2 CK — Page 21 | Examkin